merck glp 1 agonist Comparing Ozempic, Wegovy and Other GLP-1 Drugs GLP-1 Agonists Market Report 2025-2033,
Description
Sheffield C
Incretins slow gastric emptying and also curb post-meal glucagon release, decreasing post prandial glucose spikes
If ongoing trials continue to deliver positive results, triple agonist therapies for diabetes may represent the next major evolution in treating obesity, type 2 diabetes, and related metabolic diseases
2012;30(3):e146e155
Lancet 398, 143155 (2021)
